Diabetology International最新文献

筛选
英文 中文
Method comparison and agreement of a fluorescence immunoassay-based HbA1c test with a routine HPLC method. 基于荧光免疫分析法的糖化血红蛋白检测方法与常规高效液相色谱法的比较与一致性。
IF 1.1
Diabetology International Pub Date : 2026-10-14 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00936-z
Harresh Adikesavalu, Neema Raja Beaulah Budithi, Suja Ramanathan, G Veena, S Nalina Priya, D Sowmya, Arunkumar Chakkaravarthi
{"title":"Method comparison and agreement of a fluorescence immunoassay-based HbA1c test with a routine HPLC method.","authors":"Harresh Adikesavalu, Neema Raja Beaulah Budithi, Suja Ramanathan, G Veena, S Nalina Priya, D Sowmya, Arunkumar Chakkaravarthi","doi":"10.1007/s13340-026-00936-z","DOIUrl":"10.1007/s13340-026-00936-z","url":null,"abstract":"<p><strong>Background: </strong>Glycated hemoglobin (HbA1c) is widely used for diabetes diagnosis and long-term monitoring. Although high-performance liquid chromatography (HPLC) is the accepted method, its requirement for specialized instrumentation and infrastructure can limit its accessibility in some settings. Rapid point-of-care platforms based on fluorescence immunoassay (FIA) technology enable more accessible alternative. This study evaluated the analytical agreement between the TRUSTlight HbA1c fluorescence immunoassay and the HPLC comparator method.</p><p><strong>Methods: </strong>A total of 200 anonymized residual samples collected from a diagnostic laboratory in Chennai, India, between January and February 2026 were included. HbA1c levels were measured using the ion-exchange HPLC method and compared with the TRUSTlight Glycosylated Hemoglobin Test Kit. Method agreement was assessed using Bland-Altman analysis and Passing-Bablok regression. Classification agreement at the 6.5% HbA1c threshold was assessed in comparison with the HPLC comparator method.</p><p><strong>Results: </strong>Mean HbA1c values were 6.97 ± 1.90% and 6.98 ± 1.80% for HPLC and TRUSTlight FIA, respectively. Positive and negative classification agreement was 91.84 and 89.22%, with overall agreement of 90.50%. Bland-Altman analysis showed a mean bias of 0.008% and 95% limits of agreement of - 0.987% to 1.003%. At the 6.5% diagnostic cutoff, these limits corresponded to approximately - 15.2% to + 15.4% relative differences and were wider than the ± 5% NGSP manufacturer certification criterion. Passing-Bablok regression showed no significant constant or proportional bias.</p><p><strong>Conclusion: </strong>The TRUSTlight FIA showed a small mean bias relative to the HPLC comparator, although the observed limits of agreement were wider than the ± 5% NGSP manufacturer certification criterion. Further validation is needed to determine its suitability for longitudinal HbA1c monitoring.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13340-026-00936-z.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"83"},"PeriodicalIF":1.1,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13669289/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149215407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sarcopenia and muscle dysfunction in young adults with type 1 diabetes mellitus: associations with bone mineral density. 年轻成人1型糖尿病患者的肌肉减少症和肌肉功能障碍:与骨密度的关系
IF 1.1
Diabetology International Pub Date : 2026-10-14 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00938-x
Lucas Rista, Valeria Ines Rojas, Lucas R Brun, Luis Agustin Ramirez Stieben, Mercedes Lombarte, María Lorena Brance
{"title":"Sarcopenia and muscle dysfunction in young adults with type 1 diabetes mellitus: associations with bone mineral density.","authors":"Lucas Rista, Valeria Ines Rojas, Lucas R Brun, Luis Agustin Ramirez Stieben, Mercedes Lombarte, María Lorena Brance","doi":"10.1007/s13340-026-00938-x","DOIUrl":"10.1007/s13340-026-00938-x","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate bone mineral density (BMD), body composition, muscle strength, physical performance, and the prevalence of sarcopenia in young adults with type 1 diabetes mellitus (T1DM), and to explore clinical, metabolic, and skeletal correlates associated with sarcopenia.</p><p><strong>Methods: </strong>A cross-sectional study that evaluated BMD, body composition, muscle strength, and physical performance in 42 young adults with T1DM compared with 42 age- and sex-matched non-diabetic controls. DXA was used to assess areal and volumetric BMD, as well as whole-body composition, while muscle strength and function were evaluated using handgrip strength, gait speed, sit-to-stand, and timed up-and-go tests. Sarcopenia was defined following EWGSOP2 criteria.</p><p><strong>Results: </strong>Areal and volumetric BMD values did not differ between groups at the lumbar spine, femoral neck, or total hip, suggesting preserved BMD in this young population. Body composition, including appendicular skeletal muscle mass index, was also similar between groups. In contrast, the T1DM group displayed significantly reduced muscle strength and impaired physical performance across multiple functional tests. Sarcopenia was diagnosed in 23.8% of T1DM participants, whereas no cases were identified in controls (OR 23.3). Within the T1DM group, participants with sarcopenia exhibited lower femoral BMD and cortical surface BMD than those without sarcopenia.</p><p><strong>Conclusions: </strong>Young adults with T1DM exhibit a high prevalence of sarcopenia and impaired muscle function despite preserved BMD and muscle mass. Among individuals with T1DM, sarcopenia was associated with lower femoral BMD and cortical surface BMD, supporting the importance of early musculoskeletal assessment in diabetes care.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"84"},"PeriodicalIF":1.1,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13669255/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149215106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical significance of the C-reactive protein-triglyceride-glucose index in glycemic control and ischemic limb damage in type 2 diabetes with chronic limb-threatening ischemia. c反应蛋白-甘油三酯-葡萄糖指数在2型糖尿病伴慢性肢体缺血患者血糖控制及缺血性肢体损伤中的临床意义
IF 1.1
Diabetology International Pub Date : 2026-10-14 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00937-y
Hou Jianyu, Ji Donghua, Ma Qun, Zhou Mohan, Wang Longshuang, Zhong Siyi
{"title":"Clinical significance of the C-reactive protein-triglyceride-glucose index in glycemic control and ischemic limb damage in type 2 diabetes with chronic limb-threatening ischemia.","authors":"Hou Jianyu, Ji Donghua, Ma Qun, Zhou Mohan, Wang Longshuang, Zhong Siyi","doi":"10.1007/s13340-026-00937-y","DOIUrl":"10.1007/s13340-026-00937-y","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical relevance of the C-reactive protein-triglyceride-glucose index (CTI) in patients with type 2 diabetes mellitus (T2DM) complicated by chronic limb-threatening ischemia (CLTI) .</p><p><strong>Methods: </strong>A total of 520 patients with CLTI were collected and divided into two groups based on the history of T2DM: the combined T2DM group and the non-T2DM group. The CTI of the patients was calculated, and its relationship with blood glucose control levels, risk factors, and the degree of ischemia in CLTI patients was analyzed.</p><p><strong>Results: </strong>The CTI in the combined T2DM group was significantly greater than that in the non-T2DM group (<i>P</i> < 0.001). The CTI in the poorly controlled blood glucose group was significantly greater than that in the well controlled blood glucose group (<i>P</i> < 0.001). Regardless of whether CLTI patients had T2DM, the CTI in the overweight group was greater than that in the non-overweight group (<i>P</i> < 0.05). The area under the curve (AUC) for the CTI discriminating the high wound, ischemia, and foot infection (WIfI) classification was 0.813 (<i>P</i> < 0.001). Univariate and multivariate logistic regression analyses showed that an increased CTI was an independently associated factor for the high WIfI classification in CLTI patients (OR = 6.409, <i>P</i> < 0.001). Kaplan-Meier analysis revealed that patients with CLTI and high CTI levels had significantly lower 1-year amputation-free survival compared to those with low CTI levels.</p><p><strong>Conclusions: </strong>The CTI was closely related to the presence of T2DM, blood glucose control level, and overweight status in CLTI patients. The CTI has certain clinical value in discriminating the degree of ischemia in CLTI, and high CTI levels had significantly lower 1-year amputation-free survival compared to those with low CTI levels.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"82"},"PeriodicalIF":1.1,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13669265/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149215385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Responsibility sharing among children with Type 1 Diabetes and their caregivers: a cross-sectional survey from North India using the Diabetes Family Responsibility Questionnaire (DFRQ). 1型糖尿病儿童及其照顾者的责任分担:来自北印度的一项使用糖尿病家庭责任问卷(DFRQ)的横断面调查
IF 1.1
Diabetology International Pub Date : 2026-10-05 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00933-2
Anupama Choudhary, Latika Rohilla, Rupinder Kaur, Amisha Rani, Bhor Kaushal, Harpreet Kaur Gill, Jaspreet Kaur, Monika, Devi Dayal
{"title":"Responsibility sharing among children with Type 1 Diabetes and their caregivers: a cross-sectional survey from North India using the Diabetes Family Responsibility Questionnaire (DFRQ).","authors":"Anupama Choudhary, Latika Rohilla, Rupinder Kaur, Amisha Rani, Bhor Kaushal, Harpreet Kaur Gill, Jaspreet Kaur, Monika, Devi Dayal","doi":"10.1007/s13340-026-00933-2","DOIUrl":"10.1007/s13340-026-00933-2","url":null,"abstract":"<p><strong>Background: </strong>Type 1 Diabetes (T1D) management is complex due to multifaceted tasks involving both the child and parents. This study assesses responsibility sharing for diabetes care among children and caregivers and its association with glycemic control.</p><p><strong>Methods: </strong>Using descriptive design, 106 dyads of parent-child (aged 8-16 years) attending the tertiary-level diabetes clinic for at least 6 months were recruited. Data was collected using a structured interview schedule. The Diabetes Family Responsibility Questionnaire (DFRQ) was filled by both the child and parent separately. Higher DFRQ scores depict greater responsibility towards parents.</p><p><strong>Results: </strong>Most children (61.3%) were accompanied by their mother. Nearly half (47.2%) of the children belonged to the 11-13 years age group, 52.8% were females, and 74.5% had a healthy body mass index. A majority (59.4%) had HbA1c levels above 7.5%. Sixty-one (50.8%) dyads had none, eight dyads (6.7%) had more than five, and the rest had less than five items of the DFRQ marked as 'no one takes responsibility'. Dyads where the child was given more responsibility than the parent had poorer glycemic control. DFRQ scores showed a significant negative correlation with both the age of the child (<i>r</i>= - 0.388, <i>p</i> < 0.01) and HbA1c (<i>r</i>= - 0.23, <i>p</i> < 0.01) levels.</p><p><strong>Conclusion: </strong>Parents taking more responsibility predicts better glycemic control, followed by responsibility being shared equally, and glycemic control tends to decline where the adolescent was given more responsibility. Thus, it can be suggested that complete task shifting to adolescents should be done with caution until they are ready.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"79"},"PeriodicalIF":1.1,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13635061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149105529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between stigma and treatment satisfaction in patients with type 2 diabetes: a cross-sectional study. 2型糖尿病患者的病耻感与治疗满意度之间的关系:一项横断面研究
IF 1.1
Diabetology International Pub Date : 2026-10-05 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00935-0
Erika Watanabe, Hiroyuki Ito, Midori Kobayashi, Mari Tanaka
{"title":"Association between stigma and treatment satisfaction in patients with type 2 diabetes: a cross-sectional study.","authors":"Erika Watanabe, Hiroyuki Ito, Midori Kobayashi, Mari Tanaka","doi":"10.1007/s13340-026-00935-0","DOIUrl":"10.1007/s13340-026-00935-0","url":null,"abstract":"<p><strong>Aims: </strong>To investigate the comprehensive association between diabetes stigma, treatment satisfaction, and clinical parameters in patients with type 2 diabetes.</p><p><strong>Methods: </strong>This cross-sectional study included 307 Japanese outpatients. Diabetes stigma was assessed using the Kanden Institute Stigma Scale (KISS). Treatment satisfaction and perceived hyperglycemia were evaluated via the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Data regarding patient demographics, comorbidities, and antidiabetic treatments were also collected. We investigated independent factors associated with the continuous KISS score using multivariable linear regression models to prevent information loss.</p><p><strong>Results: </strong>The median age of the participants was 69 years, median body mass index (BMI) was 24.9 kg/m2, and median HbA1c was 7.1%. The median continuous KISS score was 11. In the multivariable linear regression model, after adjusting for prespecified confounders, including age, sex, duration of diabetes, and the number of antidiabetic agents, higher body mass index (BMI), the use of injection therapy, lower treatment satisfaction, and a higher perceived frequency of hyperglycemia were independently associated with higher continuous KISS scores (all <i>P</i> < 0.05). Conversely, objective HbA1c lacked a significant independent association with diabetes stigma.</p><p><strong>Conclusions: </strong>In patients with type 2 diabetes, a higher burden of diabetes stigma is independently associated with comorbid obesity, the use of injection therapy, lower treatment satisfaction, and the subjective perception of hyperglycemia, but not independently with objective HbA1c. This highlights the necessity of addressing patient experiences and psychosocial burden beyond objective glycemic targets.</p><p><strong>Graphical abstract: </strong></p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13340-026-00935-0.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"78"},"PeriodicalIF":1.1,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13635064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149105265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of imeglimin on liver enzymes and body composition in patients with MASLD and type 2 diabetes: a pilot study. 伊米霉素对MASLD合并2型糖尿病患者肝酶和体成分的影响:一项初步研究
IF 1.1
Diabetology International Pub Date : 2026-10-05 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00931-4
Kaede Fujita, Takanobu Iwadare, Takefumi Kimura, Yuma Kamijo, Taiki Okumura, Shun-Ichi Wakabayashi, Hiroyuki Kobayashi, Tomoo Yamazaki, Naoki Tanaka, Hideo Kunimoto
{"title":"Effects of imeglimin on liver enzymes and body composition in patients with MASLD and type 2 diabetes: a pilot study.","authors":"Kaede Fujita, Takanobu Iwadare, Takefumi Kimura, Yuma Kamijo, Taiki Okumura, Shun-Ichi Wakabayashi, Hiroyuki Kobayashi, Tomoo Yamazaki, Naoki Tanaka, Hideo Kunimoto","doi":"10.1007/s13340-026-00931-4","DOIUrl":"10.1007/s13340-026-00931-4","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent in patients with type 2 diabetes mellitus (T2DM), yet effective pharmacological options remain limited. Imeglimin, a novel antidiabetic agent targeting mitochondrial bioenergetics, has shown potential hepatoprotective effects in preclinical studies; however, its impact on liver function and body composition in MASLD remains unclear.</p><p><strong>Methods: </strong>This retrospective, single-center pilot study analyzed prospectively collected data from 28 patients with MASLD and T2DM who were treated with imeglimin for 6 months. Clinical and biochemical parameters were assessed at baseline and at 3 and 6 months. Body composition was evaluated using bioelectrical impedance analysis.</p><p><strong>Results: </strong>Over 6 months, fasting blood glucose decreased from 148.5 to 131.0 mg/dL (<i>p</i> = 0.015), accompanied by reductions in liver enzymes (aspartate aminotransferase: 33-26 U/L, <i>p</i> < 0.001; alanine aminotransferase: 28.5-23.5 U/L, <i>p</i> = 0.001). Body weight and body fat percentage also decreased (<i>p</i> < 0.001 and <i>p</i> = 0.018, respectively), whereas no statistically significant changes were observed in skeletal muscle mass. No serious adverse events were reported.</p><p><strong>Conclusion: </strong>Imeglimin therapy was associated with favorable changes in glycemic parameters, liver enzymes, and body composition in this pilot cohort, without a statistically significant reduction in skeletal muscle mass. These findings suggest a potential metabolic and hepatic effect of imeglimin and may be particularly relevant for patients with MASLD at risk of sarcopenia. Larger prospective studies with histological or validated non-invasive endpoints are warranted.</p><p><strong>Graphical abstract: </strong></p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13340-026-00931-4.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"80"},"PeriodicalIF":1.1,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13635075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149105427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SGLT-2 inhibitor add-on to DPP-4 inhibitor therapy significantly reduces HbA1c and body weight without increasing hypoglycaemia risk in type 2 diabetes inadequately controlled on metformin: a systematic review and meta-analysis. SGLT-2抑制剂加用DPP-4抑制剂治疗可显著降低HbA1c和体重,而不增加二甲双胍控制不充分的2型糖尿病患者的低血糖风险:一项系统综述和荟萃分析。
IF 1.1
Diabetology International Pub Date : 2026-10-05 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00934-1
Arif Saleem, Haris Shinwari, Muhammad Usman, Kamran Adil, Asfandyar Khan, Humam Shah, Iftikhar Ahmad
{"title":"SGLT-2 inhibitor add-on to DPP-4 inhibitor therapy significantly reduces HbA1c and body weight without increasing hypoglycaemia risk in type 2 diabetes inadequately controlled on metformin: a systematic review and meta-analysis.","authors":"Arif Saleem, Haris Shinwari, Muhammad Usman, Kamran Adil, Asfandyar Khan, Humam Shah, Iftikhar Ahmad","doi":"10.1007/s13340-026-00934-1","DOIUrl":"10.1007/s13340-026-00934-1","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the efficacy of combination therapy with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and dipeptidyl peptidase-4 inhibitors (DPP-4i) versus DPP-4i monotherapy in patients with type 2 diabetes mellitus (T2DM) who remained inadequately controlled on metformin.</p><p><strong>Methods: </strong>Randomized controlled trials (RCTs) investigating adults with T2DM inadequately controlled on metformin, comparing the combination of SGLT-2i plus DPP-4i versus DPP-4i add-on therapy alone were systematically reviewed. PubMed/Medline, Google Scholar, Embase, and CENTRAL were searched without language restriction. The primary outcomes were change in HbA1c and in fasting plasma glucose (FPG) from baseline, proportion of patients attainting HbA1c < 7.0%, and body weight reduction. Secondary outcomes included hypoglycemia risk, genital infection, urinary tract infection (UTI), and overall and serious adverse events (AEs). Pooled analyses were carried out using the random-effects model.</p><p><strong>Results: </strong>Eleven RCTs (3662 patients) were pooled. Compared with DPP-4i alone, adding a combination of SGLT-2i plus DPP-4i after metformin significantly reduced HbA1c (MD: - 0.47%; 95% CI (- 0.54, - 0.41); GRADE: high), increased the proportion of patients attaining HbA1c < 7.0% (RR: 1.71; 95% CI (1.52, 1.93); GRADE: moderate), reduced FPG (MD: - 15.75 mg/dL; 95% CI (- 21.56, - 9.93); GRADE: moderate), increased genital infection (RR: 2.83 (95% CI 1.02, 7.87; GRADE = moderate), and produced greater body weight reduction (MD: - 1.46 kg; 95% CI (- 1.93, - 0.99); GRADE: moderate). The risk of UTI and overall and serious AEs were insignificantly different between arms.</p><p><strong>Conclusion: </strong>The combinatorial therapy using SGLT-2i and DPP-4i produces a significantly better glycemic control and body weight compared with DPP-4i therapy alone, without increasing the overall safety burden.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13340-026-00934-1.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"81"},"PeriodicalIF":1.1,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13635070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149105534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
All-cause mortality and lower extremity outcomes across diabetic kidney disease phenotypes in patients with diabetic foot ulcers: a long-term observational cohort study (SPECTRUM-DKD study). 糖尿病足溃疡患者的全因死亡率和下肢预后:一项长期观察队列研究(SPECTRUM-DKD研究)。
IF 1.1
Diabetology International Pub Date : 2026-09-22 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00932-3
Siddharth Madhad, Raveena Singh, Sanjay Kumar Bhadada, Ashu Rastogi
{"title":"All-cause mortality and lower extremity outcomes across diabetic kidney disease phenotypes in patients with diabetic foot ulcers: a long-term observational cohort study (SPECTRUM-DKD study).","authors":"Siddharth Madhad, Raveena Singh, Sanjay Kumar Bhadada, Ashu Rastogi","doi":"10.1007/s13340-026-00932-3","DOIUrl":"10.1007/s13340-026-00932-3","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate all cause mortality and lower extremity amputation (LEA) across Diabetic kidney disease (DKD) phenotypes in patients with diabetic foot ulcers.</p><p><strong>Research design and methods: </strong>In this long term observational cohort study, we assessed 1374 adults with type 2 diabetes mellitus (2014-2024) and incident diabetic foot ulcer. They were stratified into four renal phenotypes: preserved renal function (PRF), nonproteinuric DKD (NP-DKD), proteinuric DKD (P-DKD), and overt DKD to isolate the effect of albuminuria independent of renal dysfunction. NP-DKD and P-DKD were propensity score matched 1:1 (<i>n</i> = 404) for age and diabetes duration. The primary end point was all cause mortality.</p><p><strong>Results: </strong>During a median follow-up of 4.0 years (IQR 1-7 years), 343 deaths (25.0%) occurred in the overall cohort with coronary artery disease (CAD) (38.5%) as the leading cause. Mortality differed significantly across DKD phenotypes with highest mortality in overt DKD which was comparable to NP-DKD followed by P-DKD and PRF (log-rank <i>P</i> < 0.001). In propensity-matched cohort, all cause mortality was higher in NP-DKD group (34.7%, hazard ratio, 1.54; 95% CI 1.06-2.22) than the P-DKD group (23.8%) (log-rank test <i>P</i> = 0.021). In NP-DKD, death was driven by anemia, reduced eGFR and dyslipidemia, whereas in P-DKD mortality was driven primarily by CAD. LEA was similar in NP-DKD and P-DKD (40.1% vs. 37.1%, <i>P</i> = 0.398). LEA was predominantly driven by PAD but independent of DKD phenotypes.</p><p><strong>Conclusions: </strong>NP-DKD confers mortality risk comparable to overt DKD and greater than P-DKD. PAD rather than proteinuria, is the dominant determinant of LEA across DKD phenotypes supporting a shared cardiorenal-limb vascular risk model.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13340-026-00932-3.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"77"},"PeriodicalIF":1.1,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13593958/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149024358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decoding the Indian plate: dietary patterns and their glycemic implications in Type 2 diabetes mellitus-a narrative review. 解读印度餐盘:饮食模式及其对2型糖尿病的血糖影响——一篇叙述性综述。
IF 1.1
Diabetology International Pub Date : 2026-09-22 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00930-5
Deb Saha, Rajat Kumar Mishra, Md Abubakar, V Udaya Kumar, Rutuja Vijay Kashid, Ved Prakash, Amita Rai, Nitesh Kumar, Krishna Murti
{"title":"Decoding the Indian plate: dietary patterns and their glycemic implications in Type 2 diabetes mellitus-a narrative review.","authors":"Deb Saha, Rajat Kumar Mishra, Md Abubakar, V Udaya Kumar, Rutuja Vijay Kashid, Ved Prakash, Amita Rai, Nitesh Kumar, Krishna Murti","doi":"10.1007/s13340-026-00930-5","DOIUrl":"10.1007/s13340-026-00930-5","url":null,"abstract":"<p><p>Type 2 diabetes mellitus (T2DM) is a major health challenge in India. Urbanization and nutritional factors, as well as genetic factors, contribute to the high prevalence of T2DM. The Indian diet is characterised by a high intake of carbohydrates from polished rice, wheat flour, and processed foods. This review explores the traditional and contemporary Indian diet and its role in glycemic control in patients with T2DM. Several studies have demonstrated the role of carbohydrates in glycemic control in patients with T2DM. Diets high in refined cereals have consistently shown a high glycemic response and have led to poor metabolic outcomes. On the other hand, diets containing millets, pulses, and vegetables have resulted in improved fasting glucose, postprandial glucose, and HbA1c levels. India is a large and diverse country with a wide variety of staple foods and diets. Recent studies have shown the impact of the balance and content of fiber, macronutrients, and phytochemicals in the diet, including traditional foods, with respect to glycemic control in patients with T2DM. Several dietary components commonly found in diverse traditional Indian food practices, including whole grains and millets, pulses and legumes, vegetables, dietary fibre, and appropriate protein sources, have been associated with favourable glycemic and metabolic outcomes. However, India has substantial regional dietary diversity, and current evidence remains insufficient to establish the superiority of any single traditional or regional Indian dietary pattern for the prevention or management of T2DM. These findings support the development of an evidence-based and culturally adaptable Indian plate that incorporates beneficial dietary components according to regional food preferences and individual metabolic needs.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"75"},"PeriodicalIF":1.1,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13593996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149024348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low serum free testosterone is independently associated with sarcopenic obesity in males with type 2 diabetes: a post hoc cross-sectional analysis from the impact of diabetes mellitus on dynapenia study. 低血清游离睾酮与2型糖尿病男性肌肉减少性肥胖独立相关:糖尿病对运动障碍研究影响的事后横断面分析
IF 1.1
Diabetology International Pub Date : 2026-09-22 eCollection Date: 2026-10-01 DOI: 10.1007/s13340-026-00929-y
Hiroyasu Mori, Satoko Notomi, Kasei Ko, Tetsuyuki Yasuda, Yuko Akehi, Sumiko Yoshida, Yutaka Umayahara, Sayoko Shimizu, Kayoko Ryomoto, Kazutomi Yoshiuchi, Saeko Osawa, Tsunehiko Yamamoto, Akio Kuroda, Munehide Matsuhisa
{"title":"Low serum free testosterone is independently associated with sarcopenic obesity in males with type 2 diabetes: a post hoc cross-sectional analysis from the impact of diabetes mellitus on dynapenia study.","authors":"Hiroyasu Mori, Satoko Notomi, Kasei Ko, Tetsuyuki Yasuda, Yuko Akehi, Sumiko Yoshida, Yutaka Umayahara, Sayoko Shimizu, Kayoko Ryomoto, Kazutomi Yoshiuchi, Saeko Osawa, Tsunehiko Yamamoto, Akio Kuroda, Munehide Matsuhisa","doi":"10.1007/s13340-026-00929-y","DOIUrl":"10.1007/s13340-026-00929-y","url":null,"abstract":"<p><strong>Aims: </strong>Testosterone plays a key role in maintaining skeletal muscle mass, strength, and overall physical function, while also preventing excess fat accumulation. However, limited evidence focusing specifically on free testosterone and sarcopenic obesity in males with type 2 diabetes (T2D) is available. This study aimed to investigate the association between serum free testosterone and sarcopenic obesity in males with T2D according to the newly established Japanese consensus definition.</p><p><strong>Methods: </strong>This post hoc cross-sectional analysis used data from the multicenter, cross-sectional Impact of Diabetes Mellitus on Dynapenia study. Sarcopenic obesity was defined based on the Japanese Working Group on Sarcopenic Obesity criteria as the combination of a high body mass index (BMI) or waist circumference with low grip strength, high body fat percentage, and low appendicular skeletal muscle mass adjusted for BMI. Serum free testosterone was measured, and multivariate logistic regression analysis was used to evaluate the association with sarcopenic obesity.</p><p><strong>Results: </strong>Males with sarcopenic obesity had significantly lower serum free testosterone than those without sarcopenic obesity (<i>p</i>=0.002). Multivariate analysis identified low free testosterone (<i>p</i>=0.003) as an independent correlate of sarcopenic obesity.</p><p><strong>Conclusions: </strong>Low serum free testosterone is independently associated with sarcopenic obesity in males with T2D.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13340-026-00929-y.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"17 4","pages":"76"},"PeriodicalIF":1.1,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13593974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149024335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书